Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

1(20.0%)

Phase 3

1(20.0%)

5Total

N/A(3)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06915883Not ApplicableCompleted

Experiential and Relaxation Virtual Reality as a Tool for Easing Anxiety in Seriously Ill Children

Role: collaborator

NCT02300766Recruiting

Cerebellar Mutism Syndrome Study

Role: collaborator

NCT05274386Not ApplicableCompleted

Evaluation of the Impact of SpO2 Averaging Time on Performance of an Automatic FiO2 Control System: a Randomized Study

Role: collaborator

NCT03017326Phase 3Active Not Recruiting

Paediatric Hepatic International Tumour Trial

Role: collaborator

NCT04218812Not ApplicableActive Not Recruiting

Clinical Utility of Automated Electric Source Imaging in Presurgical Evaluation

Role: collaborator

NCT04663555Phase 4Completed

Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19

Role: collaborator

NCT05638022Unknown

Pilot Project of Familial Hypercholesterolemia Screening in Newborns in the Czech Republic

Role: collaborator

NCT04404699Completed

Stimulation TcPO2 Test in the PAD Diagnosis in Diabetic Foot

Role: collaborator

All 8 trials loaded